| 摘要 |
<p>Methods and compositions are disclosed uitlizing the optically pure (2S, 4R) isomer of itraconazole. This compound is a potent drug for the treatment of local and systemic fungal, yeast, and dermatophyte infections, while avoiding the concomitant liability of adverse effects associated with the racemic mixture of itraconazole.</p> |
